Abstract
Objective
To explore the effects of 12-O -tetradecanoylphorbol -13 -acetate (TPA) on differentiation, apoptosis and related molecular mechanisms in U937 myelomonocytic leukemia cells.
Methods
Morphological changes were analyzed by phase contrast and light microscopy, expression of the monocytic differentiation maker CD11b by direct immunofluorescence staining, cell cycle distribution and apoptosis by flow cytometry, and expression of bcl -2, Bax, survivin and p21Cip1/Waf1 proteins by Western analysis.
Results
Treatment of U937 cells with 10 nmol/L TPA induced cell adherence. The adherent cells showed G0/G1 cell cycle arrest (69.0% at 24 hvs 52.1% control;P< 0.01), and morphologic changes and increased expression of the monocytic differentiation marker CD11 b (63.0% at 72 h vs 15.3% control;P< 0.01 ). In addition to these effects, about 20% of the cells still remained in suspension and exhibited a time -dependent increasing apoptosis, which reached 70.3% after 72 h of treatment (P< 0.01). TPA treatment for 24 h induced expression of p21Cip1/Waf1 in the adherent cells, but not in the non-adherent cells. Furthermore, bcl-2 and survivin expression declined in 24 h-TPA-treated non-adherent cells compared with untreated control and adherent cells, whereas no change in the expression of Bax was detected.
Conclusion
TPA induces both differentiation and apoptosis in U937 cells, which may be related to the upregulation of p21Cip1/Waf1 and downregulation of bcl-2 and survivin expression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ramirez CD, Sleiman RJ, Catchpoole DR, et al. Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells. Cell Death Differ. 2000; 7: 548–555.
Solary E, Bertrand R, Pommier Y. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia. 1994; 8: 792–797.
Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem. 1995; 270: 28495–28498.
Strair RK, Schaar D, Goodell L, et al. Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-Otetradecanoylphorbol-13-acetate. Clin Cancer Res. 2002; 8:2512–2518.
Tian JQ, Quaroni A. Involvement of p21(WAFl/Cipl) and p27 (Kipl) in intestinal epithelial cell differentiation. Am J Physiol. 1999; 276: C1245–1258.
Casini T, Pelicci PG. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene. 1999; 18: 3235–3243.
Meinhardt G, Roth J, Totok G. Protein kinase C activation modulates pro-and anti-apoptotic signaling pathways. Eur J Cell Biol. 2000; 79: 824–833.
Herrant M, Luciano F, Loubat A, et al. The protective effect of phorbol esters on Fas -mediated apoptosis in T cells. Transcriptional and postranscriptional regulation. Oncogene. 2002; 21: 4957–4968.
Suzuki A, Tsutomi Y, Yamamoto N, et al. Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol Cell Biol. 1999; 19:3842–3847.
Author information
Authors and Affiliations
Additional information
This work was supported by the Scientific Research Foundation of higher education from the Department of Education of Liaoning Province (No. 20122152).
About this article
Cite this article
Luo, Y., Liu, Y., Hou, K. et al. Molecular mechanism of differentiation and apoptosis of U937 cells induced by 12-O-tetradecanoylphorbol-13-acetate. Chin. J. Clin. Oncol. 2, 553–557 (2005). https://doi.org/10.1007/BF02761520
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02761520